Candidiasis: Clinical Trials

345 trials for Candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

247 completed, 33 unknown, 22 terminated, 20 recruiting. 73 Phase 3, 71 Not applicable, 54 Phase 2, 35 Phase 4, 28 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 373Completed 55, Terminated 7, Unknown 6, Recruiting 3, Not yet recruiting 1, Withdrawn 1
Not applicable71Completed 48, Unknown 9, Recruiting 7, Not yet recruiting 3, Terminated 3, Active not recruiting 1
Phase 254Completed 38, Unknown 6, Terminated 4, Withdrawn 3, Recruiting 2, Active not recruiting 1
Phase 435Completed 26, Terminated 4, Unknown 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 128Completed 22, Unknown 4, Active not recruiting 1, Withdrawn 1
Early Phase 15Completed 2, Active not recruiting 1, Recruiting 1, Unknown 1

Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial
Caspofungin only within the study, Caspofungin for 3 days within the study, Placebo only within the study - Candidemia, Invasive Candidiasis
Phase 4Not yet recruitingOliver Cornely, MD4202026-09-012026-09-01
Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment
Blue LED Photobiomodulation - Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis
Not applicableNot yet recruitingPatricia Lordelo1502026-07-302026-07-13
Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model
Pharmacist-Led Prescribing Optimization and Patient Counselling - Oral Lichen Planus, Recurrent Aphthous Stomatitis
Not applicableNot yet recruitingUniversity of Fujairah3362026-07-012026-07-22
Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
OCF001 Intravaginal Gel, Placebo Gel - Candidiasis, Vulvovaginal
Phase 2RecruitingSano Chemicals Inc362026-06-042026-06-15
Large Algorithm Setting and Validation Study
Nanopath Vaginitis Assay, BD Max™ Vaginal Panel, Cepheid Xpert® Xpress MVP - Bacterial Infections, Bacterial Infections and Mycoses
RecruitingNanopath, Inc10002026-06-032026-07-20
Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis
Bioithas WOMAN® - Vulvovaginal Candidiasis (VVC)
Not applicableRecruitingBioithas SL602026-05-252026-05-22
Prospective Clinical Study, Using a Medical Device (RepHegyn) as an Adjuvant in the Treatment of Fungal (Candidiasis) and Bacterial Infections
Bacterial Infections, Treatment of Fungal Infections, Candidiasis
Not yet recruitingInnate srl342026-05-012026-04-14
The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study
Vaginal lactoferrin, Usual care - Bacterial Vaginosis, Candida Vaginal
Not applicableRecruitingGuy's and St Thomas' NHS Foundation Trust1142026-04-162026-05-29
An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group
pHyph - Vulvovaginal Candidiasis (VVC)
Not applicableActive not recruitingGedea Biotech AB482026-03-032026-05-14
Biofilm Formation and Antifungal Resistance in Candida Species
Candida Infection
Not yet recruitingAssiut University3002025-12-202025-11-24
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Non-interventional study - Vulvovaginitis, Candidal, Vulvovaginal Candidiasis
RecruitingGlaxoSmithKline1002025-11-122026-09-23
Multi-Gyn FemiTotal for the Treatment and Prevention of Vulvovaginal Candidiasis Symptoms and Bacterial Vaginosis
Multi-Gyn FemiTotal - Bacterial Vaginosis, Vaginal Candidiasis
Not applicableRecruitingKaro Pharma AB802025-10-222026-10-02
Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis(VVC)
Oteseconazole (VT-1161) 150mg capsule - Vulvovaginal Candidiasis
Not yet recruitingBeijing Tsinghua Chang Gung Hospital30002025-08-102025-07-01
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Boric acid, Placebo - Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3CompletedpH-D Feminine Health LLC3332025-08-082026-10-23
A Randomized Study of a Short Duration Therapy for Candidemia
Standard of Care (SOC), Shortened duration of antifungal therapy - CANDIDEMIA
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris3622025-07-012025-03-05
One-stage Exchange in Candida Periprosthetic Infection a Suitable Way to go
Candida Infection
RecruitingUniversity Hospital, Strasbourg, France162025-05-282025-12-24
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
vaginal cooling device - Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
Not applicableRecruitingCoologics, Inc552025-05-222026-01-30
A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia
Antifungal treatment - Candidemia
Not yet recruitingAugusta University1502025-05-012025-04-04
Efficacy of the Vacucis Candida® Autovaccine
Vacucis autovaccine, Placebo - Oral Candidiasis, Oral Candidiasis Recurrent
Not applicableNot yet recruitingUniversity of Santiago de Compostela462025-04-302024-10-17
Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis
cobas® BV/CV test, BD Max™ Vaginal Panel, Cepheid Xpert Xpress MVP - Bacterial Vaginosis, Candida Vaginitis
CompletedHoffmann-La Roche7382024-12-302026-10-16

Showing 20 of 345. Sign in to see all of them.

Narrower conditions

Candidiasis, Vulvovaginal (107)  ·  Candidemia (68)  ·  Candidiasis, Invasive (64)  ·  Candidiasis, Oral (48)  ·  Mycoses (43)  ·  Torulopsis (32)  ·  HIV Infections (29)  ·  Vaginosis, Bacterial (29)  ·  Aspergillosis (25)  ·  Acquired Immunodeficiency Syndrome (18)  ·  Invasive Fungal Infections (16)  ·  Vaginitis (16)  ·  AIDS-Related Opportunistic Infections (12)  ·  AIDS-Related Complex (11)

Broader conditions

Bacterial Infections and Mycoses (344)  ·  Infections (340)  ·  Mycoses (302)  ·  Urogenital Diseases (149)  ·  Genital Diseases (147)  ·  Female Urogenital Diseases and Pregnancy Complications (122)  ·  Female Urogenital Diseases (118)  ·  Genital Diseases, Female (116)  ·  Vaginal Diseases (112)  ·  Vulvar Diseases (108)  ·  Vulvitis (108)  ·  Pathological Conditions, Signs and Symptoms (103)  ·  Vulvovaginitis (101)  ·  Invasive Fungal Infections (100)

Interventions

Fluconazole (58)  ·  Micafungin (25)  ·  Caspofungin (23)  ·  Anidulafungin (16)  ·  Voriconazole (13)  ·  Clotrimazole (12)  ·  ibrexafungerp (11)  ·  Amphotericin B (7)  ·  Miconazole (6)  ·  Nystatin (6)  ·  VT-1161 (6)  ·  Clindamycin (5)  ·  Injections (5)  ·  Itraconazole (5)  ·  posaconazole (5)

Sponsors

Pfizer (26)  ·  Merck Sharp & Dohme LLC (14)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (14)  ·  Scynexis, Inc. (11)  ·  Astellas Pharma Inc (9)  ·  National Cancer Institute (NCI) (9)  ·  Radboud University Medical Center (5)  ·  Bristol-Myers Squibb (4)  ·  Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (4)  ·  Gedea Biotech AB (4)  ·  University Hospital, Lille (4)  ·  Basilea Pharmaceutica (3)  ·  Bayer (3)  ·  Central Hospital, Nancy, France (3)  ·  Matinas BioPharma Nanotechnologies, Inc. (3)

Countries

United States (129)  ·  France (35)  ·  Spain (23)  ·  Italy (22)  ·  Brazil (19)  ·  Germany (19)  ·  Canada (18)  ·  Netherlands (17)  ·  Belgium (16)  ·  China (16)  ·  Austria (13)  ·  India (12)  ·  South Africa (11)  ·  Turkey (Türkiye) (11)  ·  Greece (9)

Top investigators

David Angulo, MD (6)  ·  Shangrong Fan, M.D. (3)  ·  Alena Jandourek, MD (2)  ·  Marc Engelhardt (2)  ·  Michail S Lionakis, M.D. (2)  ·  Peter Pappas, MD (2)  ·  Raphael F de Souza, DDS, PhD (2)  ·  Robert Krause, MD (2)

Results publications

PMID 28459966, PMID 28597967, PMID 33891293, PMID 31280481, PMID 36396498, PMID 21147825, PMID 23315320, PMID 23959319, PMID 33438477, PMID 36255448, PMID 38008099, PMID 38319878, PMID 38502709, PMID 39468640, PMID 39529079, PMID 40970688, PMID 41940006, PMID 10747150, PMID 10782340, PMID 11687311, PMID 16127033, PMID 16161031, PMID 16436724, PMID 16648432, PMID 17128343, PMID 17568028, PMID 17719934, PMID 18473572, PMID 18696746, PMID 18813103, PMID 19144094, PMID 19485785, PMID 19804626, PMID 19915602, PMID 20876174, PMID 21961941, PMID 22018278, PMID 22026929, PMID 22144537, PMID 22424952, PMID 22490643, PMID 22504098, PMID 22879929, PMID 22955439, PMID 23543609, PMID 23676114, PMID 23710653, PMID 23726546, PMID 24165173, PMID 24261608

NIH funding

2009 (6), 2008 (3), 2017 (3), 2014 (2), 2015 (1), 2018 (1), 2023 (1), M01RR000030 (1), M01RR000032 (1), M01RR000039 (1), M01RR000044 (1), M01RR000054 (1), M01RR000059 (1), M01RR000070 (1), M01RR000080 (1)